Skip to search formSkip to main contentSkip to account menu

golimumab

A human monoclonal antibody directed against the pro-inflammatory cytokine tumor necrosis factor-alpha (TNF-a) with immunosuppressive activity… 
National Institutes of Health

Related topics

Related topics

11 relations
0.5 ML golimumab 100 MG/ML Auto-Injector [Simponi]0.5 ML golimumab 100 MG/ML Prefilled Syringe1 ML golimumab 100 MG/ML Auto-Injector1 ML golimumab 100 MG/ML Auto-Injector [Simponi]

Broader (1)

Monoclonal Antibodies

Narrower (1)

Simponi

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector…
Review
2018
Review
2018
Molecular mechanisms of action of anti‐TNF‐&agr; agents – Comparison among therapeutic TNF‐&agr; antagonists
Highly Cited
2017
Highly Cited
2017
Oncostatin M drives intestinal inflammation in mice and its abundance predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease
Inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), are complex chronic inflammatory… 
Review
2016
Review
2016
Biologic Therapies and Risk of Infection and Malignancy in Patients With Inflammatory Bowel Disease: A Systematic Review and Network Meta-analysis.
Highly Cited
2015
Highly Cited
2015
A Randomized, Double‐Blind, Placebo‐Controlled, Sixteen‐Week Study of Subcutaneous Golimumab in Patients With Active Nonradiographic Axial Spondyloarthritis
Axial spondyloarthritis (SpA) is a chronic inflammatory disease characterized by back pain and stiffness. The objective of this… 
Highly Cited
2015
Highly Cited
2015
Comparative Risk of Hospitalized Infection Associated With Biologic Agents in Rheumatoid Arthritis Patients Enrolled in Medicare
The risks of hospitalized infection associated with biologic agents used to treat rheumatoid arthritis (RA) are unclear. The aim… 
Review
2011
Review
2011
TNF alpha antagonist‐induced lupus‐like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists
Background  In patients with various autoimmune and rheumatic diseases, a drug‐induced lupus‐like syndrome (DILS) has been… 
Highly Cited
2010
Highly Cited
2010
Characterization of golimumab, a human monoclonal antibody specific for human tumor necrosis factor α
We prepared and characterized golimumab (CNTO148), a human IgG1 tumor necrosis factor alpha (TNFα) antagonist monoclonal antibody… 
Review
2010
Review
2010
Pharmacology of TNF blockade in rheumatoid arthritis and other chronic inflammatory diseases.
  • P. Taylor
  • Current opinion in pharmacology (Print)
  • 2010
  • Corpus ID: 33297074
Highly Cited
2009
Highly Cited
2009
Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)